---
figid: PMC8692171__nihms-1738193-f0001
figtitle: PTEN-PI3K-AKT-mTOR pathway and therapeutic targets
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC8692171
filename: nihms-1738193-f0001.jpg
figlink: /pmc/articles/PMC8692171/figure/F1/
number: F1
caption: 'Activation of PI3K-AKT signaling can occur by binding of growth factors,
  hormones, or cytokines to receptor tyrosine kinases (RTK), leading to activation
  of phosphatidylinositol 3-phosphate kinase (PI3K). PI3K phosphorylates phosphatidylinositol-4,5-bisphosphate
  (PIP2), generating phosphatidylinositol 3,4,5-trisphosphate (PIP3), leading to the
  activation of AKT by phosphorylation at Thr308 (p-AKT). PTEN opposes the effect
  of PI3K by hydrolyzing PIP3 to PIP2. p-AKT deactivates glycogen synthase kinase-3
  β (GSK3β), which is a negative regulator of β-catenin, and suppresses the tuberous
  sclerosis complex (TSC1/TSC2), a negative regulator of mTORC1. mTORC1 suppresses
  eukaryotic translation initiation factor 4E-binding protein (4EBP1) and activates
  p-S6, leading to increased protein translation. mTORC2 modulates cytoskeletal remodeling
  and ion channel activation and leads to phosphorylation of AKT at Ser473. Pharmacological
  treatment with LY294002 and BKM120 inhibits PI3K activity. AZD5363 inhibits AKT.
  Rapamycin inhibits mTORC1 activity. Abbreviations: AKT, protein kinase B; AMPK,
  AMP-activated protein kinase; mTOR, mammalian target of rapamycin; mTORC1, mammalian
  target of rapamycin complex 1; mTORC2, mammalian target of rapamycin complex 2;
  PTEN, phosphatase and tensin homolog; PKD1, polycystin 1; LKB1, liver kinase B1;
  SGK1, serum/glucocorticoid regulated kinase 1.'
papertitle: 'PTEN mutations in autism spectrum disorder and congenital hydrocephalus:
  developmental pleiotropy and therapeutic targets.'
reftext: Tyrone DeSpenza, et al. Trends Neurosci. ;44(12):961-976.
year: '2023'
doi: 10.1016/j.tins.2021.08.007
journal_title: Trends in neurosciences
journal_nlm_ta: Trends Neurosci
publisher_name: ''
keywords: neurodevelopment disorders | ventriculomegaly | macrocephaly | mTOR | rapamycin
automl_pathway: 0.8716313
figid_alias: PMC8692171__F1
figtype: Figure
redirect_from: /figures/PMC8692171__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8692171__nihms-1738193-f0001.html
  '@type': Dataset
  description: 'Activation of PI3K-AKT signaling can occur by binding of growth factors,
    hormones, or cytokines to receptor tyrosine kinases (RTK), leading to activation
    of phosphatidylinositol 3-phosphate kinase (PI3K). PI3K phosphorylates phosphatidylinositol-4,5-bisphosphate
    (PIP2), generating phosphatidylinositol 3,4,5-trisphosphate (PIP3), leading to
    the activation of AKT by phosphorylation at Thr308 (p-AKT). PTEN opposes the effect
    of PI3K by hydrolyzing PIP3 to PIP2. p-AKT deactivates glycogen synthase kinase-3
    β (GSK3β), which is a negative regulator of β-catenin, and suppresses the tuberous
    sclerosis complex (TSC1/TSC2), a negative regulator of mTORC1. mTORC1 suppresses
    eukaryotic translation initiation factor 4E-binding protein (4EBP1) and activates
    p-S6, leading to increased protein translation. mTORC2 modulates cytoskeletal
    remodeling and ion channel activation and leads to phosphorylation of AKT at Ser473.
    Pharmacological treatment with LY294002 and BKM120 inhibits PI3K activity. AZD5363
    inhibits AKT. Rapamycin inhibits mTORC1 activity. Abbreviations: AKT, protein
    kinase B; AMPK, AMP-activated protein kinase; mTOR, mammalian target of rapamycin;
    mTORC1, mammalian target of rapamycin complex 1; mTORC2, mammalian target of rapamycin
    complex 2; PTEN, phosphatase and tensin homolog; PKD1, polycystin 1; LKB1, liver
    kinase B1; SGK1, serum/glucocorticoid regulated kinase 1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - STK11
  - PKD1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - PTEN
  - AKT1
  - AKT2
  - AKT3
  - TSC1
  - CCL26
  - TSC2
  - RHEB
  - RHEBP1
  - MTOR
  - RPTOR
  - EIF4EBP1
  - CUX1
  - SART3
  - MAPKAP1
  - RICTOR
  - MLST8
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - SGK1
  - AZD5363
  - Rapamycin
  - LY294002
---
